APOE and Alzheimer disease: Multiple epidemiological studies indicate long-term NSAIDs usage reduces AD risk by about 50% in individuals bearing one or more ε4 alleles of apolipoprotein E (apoE), which is strongly associated with increased risk of both familial and sporadic AD [107–112].